POZ - Treatment News : Syphilis Treatment Response Improves With HIV Therapy

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » June 2008

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


email print

June 9, 2008

Syphilis Treatment Response Improves With HIV Therapy

Combination antiretroviral (ARV) therapy significantly improves syphilis treatment response rates in HIV-positive people undergoing their first course of antibiotics, according to the authors of a study to be published in Clinical Infectious Diseases.

HIV can severely weaken the immune system, making it harder for medications to treat other infections and diseases. The impact of HIV-related immune suppression on the response to syphilis treatment, however, isn’t well understood. Current recommendations for the treatment of syphilis are the same for HIV-positive patients as HIV-negative patients, regardless of the health of a patient’s immune system.

Khalil Ghanem, MD, and his colleagues from Johns Hopkins School of Medicine, in Baltimore, set out to determine whether the degree of immune suppression—and the use of ARV treatment—have an impact on responses to syphilis therapy. They examined the medical records of 180 HIV-positive patients diagnosed with syphilis between 1990 and 2006. The majority of the patients were treated with penicillin.

Of the 180 patients, 39 percent experienced a syphilis treatment failure—they either failed to attain a major reduction in their syphilis antibody levels or they had a good initial antibody response that later increased again. Ghanem’s team found that people who had a CD4 count of less than 200 at the time of their syphilis diagnosis were nearly 2.5 times more likely to experience a syphilis treatment failure as people with a CD4 count above 200.

Ghanem’s group also found that combination ARV treatment reduced the risk of syphilis treatment failure by 60 percent. The more the CD4 count recovered after starting ARV treatment, they found, the greater the reduction in syphilis treatment failure risk. Ghanem’s team writes that further research on the interaction between HIV, ARV treatment and syphilis should be conducted, but that “aggressive HIV infection management” could improve syphilis treatment responses in people with HIV.

Search: syphilis, Khalil Ghanem, Johns Hopkins, penicillin


Scroll down to comment on this story.

email print

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

         


[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar
Starting Treatment
Quilt in the Capital
POZ Army


    blue_water
    New York City
    New York


    Luvlyfe27
    Huntsville
    Alabama


    cortaza100
    milwaukee
    Wisconsin


    donnyp
    liberty
    Kentucky
Click here to join POZ Personals!
Talk to Us
Poll
Do you support rapid in-home HIV testing?
Yes
No

Survey
Health 2.0

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.